Small-Cap Gains Resume Ahead Of Major Tech Earnings; UPS Faces Worst Day Ever, Bitcoin Dips Below $66,000: What's Driving Markets Tuesday?
Quest Sees Businesses Pull Back From Drug Testing -- Market Talk
Leerink Partners Adjusts Quest Diagnostics Price Target to $154 From $151, Maintains Market Perform Rating
Express News | Quest Diagnostics Shares Are Trading Lower. The Company Reported Q2 Financial Results
Quest Diagnostics on Pace for Largest Percent Decrease Since July 2023 -- Data Talk
Express News | Quest Diagnostics Shares Down 2.1% ; Co Reports Q2 Results
BofA Securities Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $150
Buy Rating Affirmed for Quest Diagnostics Amid Strong Q2 Financials and Upbeat 2024 Guidance
Quest Diagnostics (NYSE:DGX) Has Some Way To Go To Become A Multi-Bagger
Quest Diagnostics Q2 24 Earnings Conference Call At 8:30 AM ET
Express News | Quest Diagnostics Forecasts 2024 Adjusted EPS Of $8.80-$9.00 Versus Prior Guidance Of $8.72-$8.97 And Consensus Of $8.86
Express News | Quest Diagnostics Forecasts 2024 Net Revenues Of $9.5B-$9.58B Versus Prior Guidance Of $9.4B-$9.48B And Consensus Of $9.46B
Quest Diagnostics Earnings Beat by $0.02, Revenue Topped Estimates
Quest Diagnostics Beats Top-line and Bottom-line Estimates; Raises FY24 Revenue, EPS Outlook
Quest Diagnostics Q2 Profit Decreases, But Beats Estimates
Earnings Flash (DGX) QUEST DIAGNOSTICS Posts Q2 EPS $2.35, Vs. Street Est of $2.33
Express News | Quest Diagnostics Q2 2024 Adj EPS $2.35 Beats $2.34 Estimate, Sales $2.397B Beat $2.390B Estimate
Express News | Quest Diagnostics Inc: Full Year 2024 Adjusted Diluted EPS Expected to Be Between $8.80 and $9.00
Express News | Quest Diagnostics Inc: Full Year 2024 Reported Diluted EPS Now Expected to Be Between $7.57 and $7.77
Express News | Quest Diagnostics Inc: Full Year 2024 Revenues Now Expected to Be Between $9.50 Bln and $9.58 Bln